Literature DB >> 1703521

Inhibition of avian myeloblastosis virus reverse transcriptase by aurochloric acid.

M Semba1, N Tanaka, M Yamada, F Takeuchi, K Matsuta, T Miyamoto, F Hanaoka, M Ui.   

Abstract

We investigated the inhibitory effects of aurochloric acid (AuCl4H) on reverse transcriptase (RT) derived from avian myeloblastosis virus and DNA polymerase alpha (pol. alpha) purified from HeLa S3 cells. The activities of RT, pol. alpha and E. coli DNA polymerase I (pol. I) with dTTP as the substrate were inhibited 50% at AuCl4H concentrations of 18 microM, 43 microM and 230 microM, respectively. AuCl4H inhibited RT activity competitively with respect to the substrate, dTTP, and uncompetitively with the template/primer, (rA)n(dT)12-18. In assays with dGTP as the substrate, 50% inhibitions of RT, pol. alpha and pol. I activities were observed at AuCl4H concentrations of 100 microM, 450 microM and 580 microM, respectively. AuCl4H inhibited RT activity uncompetitively with respect to the substrate, dGTP, and noncompetitively with the template/primer, (rC)n(dG)12-18. AuCl4H at concentrations causing more than 50% inhibition of RT activity had little inhibitory effect on the colony-forming ability of HeLa cells or their syntheses of DNA, RNA and protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703521      PMCID: PMC5918013          DOI: 10.1111/j.1349-7006.1990.tb02688.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


reverse transcriptase avian myeloblastosis virus DNA polymerase α human immunodeficiency virus E. coli DNA polymerase I.
  11 in total

1.  Antiviral chemotherapy against HTLV-III/LAV infections.

Authors:  B Oberg
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

Review 2.  Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).

Authors:  E De Clercq
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

3.  Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue.

Authors:  L Vrang; H Bazin; G Remaud; J Chattopadhyaya; B Oberg
Journal:  Antiviral Res       Date:  1987-03       Impact factor: 5.970

4.  Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions.

Authors:  R M Snyder; C K Mirabelli; S T Crooke
Journal:  Biochem Pharmacol       Date:  1986-03-15       Impact factor: 5.858

5.  The mode of inhibitory action by aphidicolin on eukaryotic DNA polymerase alpha.

Authors:  M Oguro; C Suzuki-Hori; H Nagano; Y Mano; S Ikegami
Journal:  Eur J Biochem       Date:  1979-07

6.  Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activities.

Authors:  S T Crooke; C K Mirabelli
Journal:  Am J Med       Date:  1983-12-30       Impact factor: 4.965

7.  Inhibition of human endothelial cell proliferation by gold compounds.

Authors:  T Matsubara; M Ziff
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

8.  Purification and characterization of two forms of DNA polymerase alpha from HeLa cell nuclei.

Authors:  T Enomoto; S Tanuma; M Yamada
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

9.  Effects of coordinated gold compounds on in vitro and in situ DNA replication.

Authors:  H S Allaudeen; R M Snyder; M H Whitman; S T Crooke
Journal:  Biochem Pharmacol       Date:  1985-09-15       Impact factor: 5.858

10.  Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.

Authors:  C K Mirabelli; R K Johnson; C M Sung; L Faucette; K Muirhead; S T Crooke
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.